ESPR Financials
Esperion Therapeutics Inc - Financial statements & key metrics
Stock Price
$3.18
Market Cap
$816.89M
EPS
$-0.54
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$332.31M
Gross Profit
-
Operating Income
-
Net Income
$-51.74M
EPS (Diluted)
$-0.28
Balance Sheet Highlights
Total Assets
$343.82M
Total Liabilities
$732.54M
Shareholders Equity
-
Cash & Equivalents
$144.76M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-23.65M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-11.4%
Net Margin
-34.8%
ROE
-260.8%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ESPR revenue?
ESPR's most recent quarterly revenue was $332.31M. Annual revenue can be calculated by summing the four most recent quarters.
Is ESPR profitable?
ESPR reported a loss of $51.74M in the most recent quarter. The net profit margin is -34.8%.
What is ESPR market cap?
ESPR has a market capitalization of $816.89M, making it a small-cap stock.
Does ESPR have debt?
View ESPR's balance sheet for debt information.
What is ESPR cash flow?
Cash flow data is available in the full financial statements.